1,4-Dihydroxyanthraquinone - 96%, high purity , CAS No.81-64-1

5 Citations
  • ≥96%
Item Number
D104680
Grouped product items
SKUSizeAvailabilityPrice Qty
D104680-25g
25g
In stock
$19.90
D104680-100g
100g
In stock
$35.90
D104680-250g
250g
In stock
$79.90
D104680-500g
500g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$110.90
View related series
anthraquinones Carbonyl compound

Basic Description

SynonymsQuinizarin | 1,4-Dihydroxyanthraquinone | 81-64-1 | 1,4-dihydroxyanthracene-9,10-dione | Quinizarine | Chinizarin | Solvent Orange 86 | 1,4-Dihydroxyanthrachinon | Smoke Orange R | 1,4-Dihydroxy-9,10-anthraquinone | Macrolex Orange GG | 9,10-Anthracenedione, 1,4-dihydroxy- | Ant
Specifications & Purity≥96%
Shipped InNormal
Product Description

1,4-Dihydroxyanthraquinone is an organic dye molecule with an aromatic structure. It is a derivative of anthraquinone bearing hydroxyl moieties. They may find uses in pharmacological, biochemical and dye industries. Anthraquinone dye are resistant to degradation.


application:

1,4-Dihydroxyanthraquinone may be used in the synthesis of cyclopentanoids by cyclization of α,β-unsaturated aldehyde with 1, 4 1,4-Dihydroxyanthraquinone. It has been studied as a long range emissive ratiometric fluorescent probe for live cell imaging.

Associated Targets(Human)

ESR1 Tclin Estrogen receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
RUNX1 Tbio Runt-related transcription factor 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
VDR Tclin Vitamin D3 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
KMT2A Tchem Histone-lysine N-methyltransferase 2A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CSNK1D Tchem Casein kinase I isoform delta (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TXNRD1 Tclin Thioredoxin reductase 1, cytoplasmic (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TXNRD2 Tbio Thioredoxin reductase 2, mitochondrial (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
UGT2B15 Tbio UDP-glucuronosyltransferase 2B15 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
UGT1A1 Tchem UDP-glucuronosyltransferase 1-1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
UGT1A4 Tbio UDP-glucuronosyltransferase 1-4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
UGT1A9 Tbio UDP-glucuronosyltransferase 1-9 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TOP2A Tclin DNA topoisomerase 2-alpha (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TTR Tclin Transthyretin (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAOB Tclin Amine oxidase [flavin-containing] B (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAOA Tclin Amine oxidase [flavin-containing] A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
UGT1A6 Tbio UDP-glucuronosyltransferase 1-6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAPT Tclin Microtubule-associated protein tau (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CSNK1A1 Tchem Casein kinase I isoform alpha (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CSNK1G1 Tchem Casein kinase I isoform gamma-1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
VDR Tclin Vitamin D receptor (26531 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOB Tclin Monoamine oxidase B (8835 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1G1 Tchem Casein kinase I gamma 1 (2496 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1A1 Tchem Casein kinase I alpha (2581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UGT1A4 Tbio UDP-glucuronosyltransferase 1A4 (288 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DLD-1 (17511 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DMS-273 (14108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M14 (47487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MES-SA (905 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-4 (44535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-5 (45555 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Raji (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXF 393 (41971 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RXF 631 (11415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SN12C (47755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-19 (46794 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-78 (14240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TK-10 (45540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-62 (47335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
XF498 (12972 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H322M (45589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ttr Transthyretin (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Top2 DNA topoisomerase II (15 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus mutans (2687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brugia malayi (1377 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16 (5829 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L929 (3802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Txnrd2 Thioredoxin reductase 2, mitochondrial (18 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Txnrd1 Thioredoxin reductase 1, cytoplasmic (45279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapt Microtubule-associated protein tau (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ffp 4'-phosphopantetheinyl transferase ffp (24982 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Estrogen receptor (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

Pubchem Sid488180130
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488180130
IUPAC Name 1,4-dihydroxyanthracene-9,10-dione
INCHI InChI=1S/C14H8O4/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-6,15-16H
InChi Key GUEIZVNYDFNHJU-UHFFFAOYSA-N
Canonical SMILES C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O)O
Isomeric SMILES C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O)O
WGK Germany 2
RTECS CB6600000
PubChem CID 6688
Molecular Weight 240.21
Beilstein 1914036
Reaxy-Rn 1914036

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

8 results found

Lot NumberCertificate TypeDateItem
I2308327Certificate of AnalysisDec 13, 2022 D104680
I2308328Certificate of AnalysisDec 13, 2022 D104680
I2308437Certificate of AnalysisDec 13, 2022 D104680
I2308464Certificate of AnalysisDec 13, 2022 D104680
I2308465Certificate of AnalysisDec 13, 2022 D104680
I2308466Certificate of AnalysisDec 13, 2022 D104680
I2308467Certificate of AnalysisDec 13, 2022 D104680
K1819121Certificate of AnalysisSep 19, 2022 D104680

Chemical and Physical Properties

SolubilitySoluble in Benzene
Flash Point(°F)222 °C
Flash Point(°C)222°C
Boil Point(°C)450°C
Melt Point(°C)195-200 °C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 2
RTECS CB6600000
Reaxy-Rn 1914036
Merck Index 8064

Related Documents

Citations of This Product

1. Rui Gao, Zihao Jiang, Xiuyu Wu, Zhihong Cai, Nan Sang.  (2023)  Metabolic regulation of tumor cells exposed to different oxygenated polycyclic aromatic hydrocarbons.  SCIENCE OF THE TOTAL ENVIRONMENT,    (15): (167833).  [PMID:37839476]
2. Xu Liu, Xiao Han, Yushuang Shang, Lijuan Wang, Jian Shen, Jiang Yuan.  (2023)  Hydrogen sulfide releasing poly(γ-glutamic acid) biocomposite hydrogel with monitoring, antioxidant, and antibacterial properties for diabetic wound healing.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,  253  (1): (127053).  [PMID:37774813]
3. Yunxiao Wang, Chang Liu, Shanshan Tang, Jing Tian, Yi Wang, Yi Yang.  (2023)  Thermodynamics, kinetics and structure-activity relationship of hydroxyanthraquinones scavenging free radicals.  Food Bioscience,  53  (102705).  [PMID:]
4. Peiyuan Su, Jianing Yue, Qingyu Kong, Wenkai Zhang.  (2023)  Excited state intramolecular proton transfer in 1,4-dihydroxyanthraquinone.  CHEMICAL PHYSICS,  566  (111783).  [PMID:]
5. Yuanyuan Song, Ziqi Wang, Yijing Long, Yang Mao, Feng Jiang, Yuanyuan Lu.  (2022)  2-Alkyl-anthraquinones inhibit Candida albicans biofilm via inhibiting the formation of matrix and hyphae.  RESEARCH IN MICROBIOLOGY,  173  (103955).  [PMID:35550403]

References

1. X Ma,C C Cheng,R T Su.  (1984-02-24)  Synthesis of simian virus 40 chromosomes in nuclear extracts from dihydroxyanthraquinone-treated cells..  Biochimica et biophysica acta,  781  ((1-2)): (173-182).  [PMID:6320893]
2. D F Liberman,R C Fink,F L Schaefer,R J Mulcahy,A A Stark.  (1982-06-01)  Mutagenicity of anthraquinone and hydroxylated anthraquinones in the Ames/Salmonella microsome system..  Applied and environmental microbiology,  43  ((6)): (1354-1359).  [PMID:7103489]
3. N J Hao,M P Huang,H Lee.  (1995-05-01)  Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline..  Mutation research,  328  ((2)): (183-191).  [PMID:7739602]
4. J Fostel,D Montgomery,P Lartey.  (1996-05-01)  Comparison of responses of DNA topoisomerase I from Candida albicans and human cells to four new agents which stimulate topoisomerase-dependent DNA nicking..  FEMS microbiology letters,  138  ((2-3)): (105-111).  [PMID:9026436]
5. M M Fiallo,A Garnier-Suillerot,B Matzanke,H Kozlowski.  (1999-08-18)  How Fe3+ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx..  Journal of inorganic biochemistry,  75  ((2)): (105-115).  [PMID:10450605]
6. Mugunthu R Dhananjeyan,Youli P Milev,Michael A Kron,Muraleedharan G Nair.  (2005-04-15)  Synthesis and activity of substituted anthraquinones against a human filarial parasite, Brugia malayi..  Journal of medicinal chemistry,  48  ((8)): (2822-2830).  [PMID:15828820]
7. Sung-Woo Kim,Byoung-Kee Jo,Ji-Hean Jeong,Sun-Uk Choi,Yong-Il Hwang.  (2005-12-29)  Induction of extracellular matrix synthesis in normal human fibroblasts by anthraquinone isolated from Morinda citrifolia (Noni) fruit..  Journal of medicinal food,  ((4)): (552-555).  [PMID:16379572]
8. D M Fouad,N M Ismail,M A El-Gahami,S A Ibrahim.  (2006-10-20)  Kinetics of the substitution of dehydroacetic acid in tris (dehydroacetato) Fe(III) complex by 8-hydroxyquinoline, di- and tetra-hydroxyquinone..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  67  ((2)): (564-567).  [PMID:17049303]
9. Tom Coenye,Kris Honraet,Petra Rigole,Pol Nadal Jimenez,Hans J Nelis.  (2007-01-16)  In vitro inhibition of Streptococcus mutans biofilm formation on hydroxyapatite by subinhibitory concentrations of anthraquinones..  Antimicrobial agents and chemotherapy,  51  ((4)): (1541-1544).  [PMID:17220400]
10. P Guiraud,J L Bonnet,A Boumendjel,M Kadri-Dakir,M Dusser,J Bohatier,R Steiman.  (2007-01-30)  Involvement of Tetrahymena pyriformis and selected fungi in the elimination of anthracene, and toxicity assessment of the biotransformation products..  Ecotoxicology and environmental safety,  69  ((2)): (296-305).  [PMID:17257678]
11. Zhang-Gao Le,Zong-Bo Xie,Min Ying.  (2007-10-27)  Ionic liquid-promoted ring-closure reactions between 1,4-dihydroxyanthraquinone and diamines..  Molecules (Basel, Switzerland),  11  ((6)): (464-468).  [PMID:17962779]
12. Noufal Kandoth,Sharmistha Dutta Choudhury,Tulsi Mukherjee,Haridas Pal.  (2009-02-28)  Host-guest interaction of 1,4-dihydroxy-9,10-anthraquinone (quinizarin) with cyclodextrins..  Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology,  ((1)): (82-90).  [PMID:19247534]
13. J Whitaker,J S Chaplow,E Potter,W A Scott,S Hopkin,M Harman,I Sims,N Sorokin.  (2009-04-29)  The comparative toxicity to soil invertebrates of natural chemicals and their synthetic analogues..  Chemosphere,  76  ((3)): (345-352).  [PMID:19398118]
14. Anna Frackowiak,Przemysław Skibiński,Wiesław Gaweł,Ewa Zaczyńska,Anna Czarny,Roman Gancarz.  (2009-12-17)  Synthesis of glycoside derivatives of hydroxyanthraquinone with ability to dissolve and inhibit formation of crystals of calcium oxalate. Potential compounds in kidney stone therapy..  European journal of medicinal chemistry,  45  ((3)): (1001-1007).  [PMID:20005021]
15. Duy Duc Nguyen,Nykola C Jones,Søren Vrønning Hoffmann,Jens Spanget-Larsen.  (2010-06-15)  Synchrotron radiation linear dichroism (SRLD) investigation of the electronic transitions of quinizarin, chrysazin, and anthrarufin..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  77  ((1)): (279-286).  [PMID:20541965]
16. Francesca Sorrentino,Anastasia Karioti,Paola Gratteri,Maria Pia Rigobello,Guido Scutari,Luigi Messori,Alberto Bindoli,Matteo Chioccioli,Chiara Gabbiani,Maria Camilla Bergonzi,Anna Rita Bilia.  (2010-11-26)  Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones..  Bioorganic & medicinal chemistry,  19  ((1)): (631-641).  [PMID:21106380]
17. Mohammad Saeid Hosseini,Ahmad Hosseini-Bandegharaei.  (2011-05-03)  Comparison of sorption behavior of Th(IV) and U(VI) on modified impregnated resin containing quinizarin with that conventional prepared impregnated resin..  Journal of hazardous materials,  190  ((1-3)): (755-765).  [PMID:21530077]
18. Xiaopeng Xuan,Xinsheng Wang,Na Wang.  (2011-05-13)  Theoretical study of molecular structure and vibrational spectra of 1,4-dihydroxyanthraquinone..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  79  ((5)): (1091-1098).  [PMID:21561800]
19. Guang-Zhu Jin,Hai-Shan Jin,Li-Li Jin.  (2011-08-04)  Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells..  Archives of pharmacal research,  34  ((7)): (1071-1076).  [PMID:21811913]
20. E Tramontano,T Kharlamova,L Zinzula,F Esposito.  (2011-10-19)  Effects of new quinizarin derivatives on both HCV NS5B RNA polymerase and HIV-1 reverse transcriptase associated ribonuclease H activities..  Journal of chemotherapy (Florence, Italy),  23  ((5)): (273-276).  [PMID:22005058]
21. Christopher Batchelor-McAuley,Ivan B Dimov,Leigh Aldous,Richard G Compton.  (2011-11-24)  The electrochemistry of quinizarin revealed through its mediated reduction of oxygen..  Proceedings of the National Academy of Sciences of the United States of America,  108  ((50)): (19891-19895).  [PMID:22109547]
22. Saadia Andleeb,Naima Atiq,Geoff D Robson,Safia Ahmed.  (2011-12-14)  An investigation of anthraquinone dye biodegradation by immobilized Aspergillus flavus in fluidized bed bioreactor..  Environmental science and pollution research international,  19  ((5)): (1728-1737).  [PMID:22161118]
23. A R Tehrani-Bagha,R G Singh,K Holmberg.  (2012-03-27)  Solubilization of two organic dyes by cationic ester-containing gemini surfactants..  Journal of colloid and interface science,  376  ((1)): (112-118).  [PMID:22444485]
24. Farid A Badria,Ahmed S Ibrahim.  (2013-05-30)  Evaluation of natural anthracene-derived compounds as antimitotic agents..  Drug discoveries & therapeutics,  ((2)): (84-89).  [PMID:23715507]
25. Ardeshir Shokrollahi,Roghayeh Aghaei.  (2013-09-26)  Spectrophotometeric determination of trace amounts of Al3+ ion in water samples after cloud point extraction using quinizarin as a complexing agent..  Environmental monitoring and assessment,  186  ((2)): (1113-1121).  [PMID:24065134]
26. T S Koch,R P Rava.  (1990-08-15)  Interpreting the visible absorption bands of 1,4-(dihydroxy)-9,10-anthraquinone and its metal chelates..  Biophysical chemistry,  36  ((3)): (187-199).  [PMID:2289021]
27. Giorgio Cozza,Alessandra Gianoncelli,Monica Montopoli,Laura Caparrotta,Andrea Venerando,Flavio Meggio,Lorenzo A Pinna,Giuseppe Zagotto,Stefano Moro.  (2008-09-19)  Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening..  Bioorganic & medicinal chemistry letters,  18  ((20)): (5672-5675).  [PMID:18799313]
28. Kunihiko Ishii,Satoshi Takeuchi,Tahei Tahara.  (2009-08-07)  Infrared-induced coherent vibration of a hydrogen-bonded system: effects of mechanical and electrical anharmonic couplings..  The Journal of chemical physics,  131  ((4)): (044512-044512).  [PMID:19655899]
29. Stefania Rossi,Claudio Tabolacci,Alessandro Lentini,Bruno Provenzano,Fabrizio Carlomosti,Simona Frezzotti,Simone Beninati.  (2010-03-25)  Anthraquinones danthron and quinizarin exert antiproliferative and antimetastatic activity on murine B16-F10 melanoma cells..  Anticancer research,  30  ((2)): (445-449).  [PMID:20332452]
30. Meiling Wang,Guowen Meng,Qing Huang,Yiwu Qian.  (2011-12-02)  Electrospun 1,4-DHAQ-doped cellulose nanofiber films for reusable fluorescence detection of trace Cu2+ and further for Cr3+..  Environmental science & technology,  46  ((1)): (367-373).  [PMID:22129160]
31. M B Gholivand,S Kashanian,H Peyman.  (2011-12-24)  DNA-binding, DNA cleavage and cytotoxicity studies of two anthraquinone derivatives..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  87  (232-240).  [PMID:22192418]
32. Andrzej Blachecki,Justyna Mech-Piskorz,Marta Gajewska,Krzysztof Mech,Kacper Pilarczyk,Konrad Szaciłowski.  (2017-04-28)  Organotitania-Based Nanostructures as a Suitable Platform for the Implementation of Binary, Ternary, and Fuzzy Logic Systems..  Chemphyschem : a European journal of chemical physics and physical chemistry,  18  ((13)): (1798-1810).  [PMID:28449282]
33. Rui Gao, Zihao Jiang, Xiuyu Wu, Zhihong Cai, Nan Sang.  (2023)  Metabolic regulation of tumor cells exposed to different oxygenated polycyclic aromatic hydrocarbons.  SCIENCE OF THE TOTAL ENVIRONMENT,    (15): (167833).  [PMID:37839476]
34. Xu Liu, Xiao Han, Yushuang Shang, Lijuan Wang, Jian Shen, Jiang Yuan.  (2023)  Hydrogen sulfide releasing poly(γ-glutamic acid) biocomposite hydrogel with monitoring, antioxidant, and antibacterial properties for diabetic wound healing.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,  253  (1): (127053).  [PMID:37774813]
35. Yunxiao Wang, Chang Liu, Shanshan Tang, Jing Tian, Yi Wang, Yi Yang.  (2023)  Thermodynamics, kinetics and structure-activity relationship of hydroxyanthraquinones scavenging free radicals.  Food Bioscience,  53  (102705).  [PMID:]
36. Peiyuan Su, Jianing Yue, Qingyu Kong, Wenkai Zhang.  (2023)  Excited state intramolecular proton transfer in 1,4-dihydroxyanthraquinone.  CHEMICAL PHYSICS,  566  (111783).  [PMID:]
37. Yuanyuan Song, Ziqi Wang, Yijing Long, Yang Mao, Feng Jiang, Yuanyuan Lu.  (2022)  2-Alkyl-anthraquinones inhibit Candida albicans biofilm via inhibiting the formation of matrix and hyphae.  RESEARCH IN MICROBIOLOGY,  173  (103955).  [PMID:35550403]

Solution Calculators